Invention Grant
US07754884B2 Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging
有权
靶向NIR成像剂用于治疗功效监测,深层组织疾病分界和深层组织成像
- Patent Title: Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging
- Patent Title (中): 靶向NIR成像剂用于治疗功效监测,深层组织疾病分界和深层组织成像
-
Application No.: US11149602Application Date: 2005-06-10
-
Publication No.: US07754884B2Publication Date: 2010-07-13
- Inventor: Darryl J. Bornhop , H. Charles Manning , Mingfeng Bai , Shelby K. Wyatt
- Applicant: Darryl J. Bornhop , H. Charles Manning , Mingfeng Bai , Shelby K. Wyatt
- Applicant Address: US TN Nashville
- Assignee: Vanderbilt University
- Current Assignee: Vanderbilt University
- Current Assignee Address: US TN Nashville
- Agency: Stites & Harbison PLLC
- Agent Richard S. Myers, Jr.
- Main IPC: C07D217/00
- IPC: C07D217/00

Abstract:
Compounds and methods related to NIR molecular imaging, in-vitro and in-vivo functional imaging, therapy/efficacy monitoring, and cancer and metastatic activity imaging. Compounds and methods demonstrated pertain to the field of peripheral benzodiazepine receptor imaging, metabolic imaging, cellular respiration imaging, cellular proliferation imaging as targeted agents that incorporate signaling agents.
Public/Granted literature
Information query